Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.9908
Delayed Data
As of 3:59pm ET
 -0.0292 / -2.86%
Today’s Change
0.82
Today|||52-Week Range
2.57
-24.94%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$27.2M

Company Description

Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of oral small molecule drugs for unmet medical needs that treat male and female reproductive disorders. Its current product pipeline consists of Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in Woodlands, TX.

Contact Information

Repros Therapeutics, Inc.
2408 Timberloch Place
Woodlands Texas 77380
P:(281) 719-3400
Investor Relations:

Employees

Shareholders

Individual stakeholders9.47%
Other institutional13.31%
Mutual fund holders12.98%

Top Executives

Larry M. DillahaPresident, Chief Executive Officer & Director
Katherine A. AndersonCFO, Secretary & Chief Accounting Officer
Joachim F. WernickeChief Medical Officer
Jaye L. ThompsonSenior Vice President-Clinical & Regulatory